Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)
China · Delayed Price · Currency is CNY 21.90
+0.35 (1.62%)
Oct 24, 2025, 2:45 PM CST
SHE:300482 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 2,732 | 3,060 | 2,760 | 5,674 | 3,354 | 2,805 | Upgrade |
Other Revenue | 3.7 | 5.07 | 5.22 | 6.89 | 7.11 | 5.82 | Upgrade |
| 2,735 | 3,065 | 2,765 | 5,681 | 3,361 | 2,811 | Upgrade | |
Revenue Growth (YoY) | -4.08% | 10.85% | -51.33% | 69.01% | 19.57% | 35.64% | Upgrade |
Cost of Revenue | 1,004 | 1,107 | 1,040 | 2,747 | 1,396 | 870.75 | Upgrade |
Gross Profit | 1,731 | 1,957 | 1,725 | 2,933 | 1,965 | 1,940 | Upgrade |
Selling, General & Admin | 890.31 | 905.85 | 877.11 | 1,157 | 910.24 | 819.99 | Upgrade |
Research & Development | 388.42 | 411.52 | 378 | 418.84 | 391.09 | 279.43 | Upgrade |
Other Operating Expenses | 31.41 | 14.03 | 9.51 | 15.95 | 9.04 | 9.63 | Upgrade |
Operating Expenses | 1,339 | 1,367 | 1,268 | 1,609 | 1,330 | 1,115 | Upgrade |
Operating Income | 391.99 | 590.27 | 456.73 | 1,324 | 634.64 | 825.49 | Upgrade |
Interest Expense | -30.64 | -30.47 | -29.93 | -32.53 | -27.76 | -11.14 | Upgrade |
Interest & Investment Income | 19.34 | 20.53 | 58.71 | 64.93 | 50.48 | 40.51 | Upgrade |
Currency Exchange Gain (Loss) | -0.12 | 11.46 | 10.99 | 30.58 | -20.62 | -23.62 | Upgrade |
Other Non Operating Income (Expenses) | -5.32 | -4.16 | -0.59 | -6.59 | -5.67 | -3.96 | Upgrade |
EBT Excluding Unusual Items | 375.26 | 587.63 | 495.91 | 1,381 | 631.08 | 827.28 | Upgrade |
Impairment of Goodwill | - | - | -3.95 | -38.56 | -5.87 | -71.74 | Upgrade |
Gain (Loss) on Sale of Investments | 28.99 | 25.75 | 14.8 | 12.81 | 10.55 | 0.24 | Upgrade |
Gain (Loss) on Sale of Assets | 0.76 | 0.76 | 0.08 | -10.4 | -10.34 | -2.51 | Upgrade |
Asset Writedown | -6.17 | -5.96 | -10.77 | -29.96 | - | -44.37 | Upgrade |
Other Unusual Items | 30.06 | 21.29 | 44.7 | 50.11 | 55.07 | 22.04 | Upgrade |
Pretax Income | 428.89 | 629.46 | 540.76 | 1,365 | 680.49 | 730.93 | Upgrade |
Income Tax Expense | 31.78 | 64.25 | 53.33 | 174.41 | 47.91 | 114.13 | Upgrade |
Earnings From Continuing Operations | 397.11 | 565.22 | 487.43 | 1,190 | 632.58 | 616.81 | Upgrade |
Minority Interest in Earnings | -2.08 | -3.59 | 0.2 | 6.94 | 1.85 | 17.36 | Upgrade |
Net Income | 395.03 | 561.63 | 487.62 | 1,197 | 634.43 | 634.17 | Upgrade |
Net Income to Common | 395.03 | 561.63 | 487.62 | 1,197 | 634.43 | 634.17 | Upgrade |
Net Income Growth | -22.38% | 15.18% | -59.27% | 88.68% | 0.04% | 63.67% | Upgrade |
Shares Outstanding (Basic) | 479 | 464 | 443 | 442 | 444 | 440 | Upgrade |
Shares Outstanding (Diluted) | 479 | 464 | 443 | 442 | 444 | 440 | Upgrade |
Shares Change (YoY) | 6.06% | 4.71% | 0.36% | -0.44% | 0.74% | -0.33% | Upgrade |
EPS (Basic) | 0.83 | 1.21 | 1.10 | 2.71 | 1.43 | 1.44 | Upgrade |
EPS (Diluted) | 0.83 | 1.21 | 1.10 | 2.71 | 1.43 | 1.44 | Upgrade |
EPS Growth | -26.81% | 10.00% | -59.41% | 89.51% | -0.69% | 64.22% | Upgrade |
Free Cash Flow | -141.3 | 43.5 | -104.05 | 1,099 | 208.44 | 642.33 | Upgrade |
Free Cash Flow Per Share | -0.29 | 0.09 | -0.23 | 2.49 | 0.47 | 1.46 | Upgrade |
Dividend Per Share | 0.400 | 0.400 | 0.400 | 0.500 | 0.300 | 0.385 | Upgrade |
Dividend Growth | - | - | -20.00% | 66.67% | -22.00% | 100.00% | Upgrade |
Gross Margin | 63.29% | 63.87% | 62.37% | 51.64% | 58.46% | 69.02% | Upgrade |
Operating Margin | 14.33% | 19.26% | 16.52% | 23.31% | 18.88% | 29.37% | Upgrade |
Profit Margin | 14.44% | 18.32% | 17.64% | 21.07% | 18.88% | 22.56% | Upgrade |
Free Cash Flow Margin | -5.17% | 1.42% | -3.76% | 19.35% | 6.20% | 22.85% | Upgrade |
EBITDA | 584.79 | 796.73 | 709.1 | 1,569 | 817.3 | 965.33 | Upgrade |
EBITDA Margin | 21.38% | 26.00% | 25.65% | 27.62% | 24.32% | 34.34% | Upgrade |
D&A For EBITDA | 192.8 | 206.45 | 252.37 | 244.63 | 182.66 | 139.85 | Upgrade |
EBIT | 391.99 | 590.27 | 456.73 | 1,324 | 634.64 | 825.49 | Upgrade |
EBIT Margin | 14.33% | 19.26% | 16.52% | 23.31% | 18.88% | 29.37% | Upgrade |
Effective Tax Rate | 7.41% | 10.21% | 9.86% | 12.78% | 7.04% | 15.61% | Upgrade |
Revenue as Reported | 2,735 | 3,065 | 2,765 | 5,681 | 3,361 | 2,811 | Upgrade |
Advertising Expenses | - | - | - | - | - | 221.25 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.